Dear Members of the United States Congress: On behalf of 2.5 million activists in all fifty states, Americans for Prosperity urges you to consider the following principles as you consider legislation providing funding following September 30. Extend current spending levels into the 114th Congress. While current spending levels are already too high, the legislature should […]
By Erin Amsberry A recent study conducted by Truth in Accounting named Missouri “a sinkhole state” as it came in ranked as the 31st worst state in the nation for financial stability. Even though Missouri has measures in place that require legislators to balance the budget, their misleading ways of accounting allow Missouri’s financial situation […]
Much has been written over the costs and shortcomings of the beleaguered bank as well as its corporate welfare aspects. In fact, one notable politician called Ex-Im “little more than a fund for corporate welfare” – but that was before he was elected president. What has been less discussed, however, is that for every job the Ex-Im bank “supports “it destroys as many, if not more, American jobs.
A recent Congressional hearing revealed just how deeply corruption appears to run at the taxpayer-backed Export-Import Bank (Ex-Im), and the lengths to which the bank’s defenders will go to try and paper over the controversial bank’s problems.
Politicians have been trying to provide affordable prescription drugs for more than a decade. Before the Patient Protection and Affordable Care Act, also known as Obamacare, there was Medicare Part D seeking to lower costs for senior citizens. Unfortunately for politicians, breakthrough new drugs often take billions of dollars and millions of man hours to produce and higher prices are needed to recoup these costs; such is the situation with the new Hepatitis C cure courtesy of Gilead Sciences.